Oncocyte Corporation - Common Stock (OCX)
2.1600
+0.0300 (1.41%)
Oncocyte Corporation is a biotechnology company focused on developing innovative diagnostic solutions for cancer patients
The company specializes in the discovery and commercialization of proprietary tests that aid in the diagnosis, prognosis, and treatment selection for various types of cancer. By employing advanced genomics and other cutting-edge technologies, Oncocyte aims to provide healthcare professionals with valuable insights to improve patient outcomes and streamline the decision-making process in oncology. Through its research and development efforts, the company seeks to enhance precision medicine and support personalized treatment strategies in the fight against cancer.
Frequently Asked Questions
Is Oncocyte Corporation - Common Stock publicly traded?
Yes, Oncocyte Corporation - Common Stock is publicly traded.
What exchange does Oncocyte Corporation - Common Stock trade on?
Oncocyte Corporation - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Oncocyte Corporation - Common Stock?
The ticker symbol for Oncocyte Corporation - Common Stock is OCX on the Nasdaq Stock Market
What is the current price of Oncocyte Corporation - Common Stock?
The current price of Oncocyte Corporation - Common Stock is 2.160
When was Oncocyte Corporation - Common Stock last traded?
The last trade of Oncocyte Corporation - Common Stock was at 4:00 pm EST on February 5th, 2025